Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Skin Res Technol ; 30(7): e13818, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38924131

RESUMO

BACKGROUND: To date, there are no accepted outcome measures to monitor morphea, and consensus on specific monitoring criteria for morphea remains elusive. A few studies have assessed the criterion validity of skin ultrasound in morphea. So, in this study, we approach ultrasound findings in morphea lesions. MATERIAL AND METHODS: This was a retrospective-analytical study conducted between December 2021 and May 2023. Patients were clinically evaluated at a dermatology outpatient clinic and then referred for high-frequency ultrasound (HF-US) evaluation and were selected to be included in this study. The lesions were confirmed by histopathology as well. Sonographic evaluations were performed on the lesion site and the symmetrical uninvolved other side. Dermal thickness and dermal echogenicities were recorded. Statistical analysis of group differences was performed by using the 2-tailed Student t-test. A p-value of less than 0.05 was considered statistically significant. RESULTS: Forty-one morphea lesions in the inflammatory phase of 27 patients were included in the study. The mean dermal thickness of morphea lesions was 1107.97 ± 414.3 and the mean dermal thickness of the control side was 1094.65 ± 331.06, The difference between these two variables was not statistically significant. The mean dermal density of lesions was 49.13 ± 18.97 and the mean dermal density of the control side was 52.22 ± 25.33. The difference between these two variables was not statistically significant. CONCLUSION: This study shows that HF-US indicated increasing dermal thickness and reducing the dermal density of the morphea lesions in the inflammatory phase confirmed with the histopathology.


Assuntos
Esclerodermia Localizada , Ultrassonografia , Humanos , Esclerodermia Localizada/diagnóstico por imagem , Esclerodermia Localizada/patologia , Estudos Retrospectivos , Feminino , Masculino , Ultrassonografia/métodos , Adulto , Pessoa de Meia-Idade , Adolescente , Adulto Jovem , Pele/diagnóstico por imagem , Pele/patologia , Criança
2.
Pediatr Dermatol ; 41(2): 229-233, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38305508

RESUMO

BACKGROUND: Morphea, or localized scleroderma, is an inflammatory, fibrosing skin disorder that can be progressive and debilitating. Infrared thermography frequently has false positive results. The aim of this study was to assess the ability of multispectral imaging to predict disease progression in children with morphea. METHODS: Children with morphea were recruited between 2016 and 2022. Multispectral images of affected and matched contralateral unaffected sites were obtained using the Antera™ 3D camera. Clinical assessment was performed using the Localized Scleroderma Assessment Tool (LoSCAT). Children were followed up every 3 months for imaging and clinical review. The main outcome measurement was correlation of hemoglobin gradient between affected and matched contralateral unaffected tissue and progression. RESULTS: Of 17 children, the average age was 12 years (range 6-18 years); most were female (76.5%) and white (94.1%). Nearly two-thirds (64.7%) had linear morphea, 35.2% had plaque morphea; 58.8% had been treated with systemic agents. The average LoSCAT score was 20.6 (range 5-73). The average hemoglobin gradient between affected and matched contralateral unaffected skin was four times higher in those who had progression (average differential 0.3, range 0.1-0.4) compared to those who did not (average differential 0.08, range 0.02-0.15). Using a cut off of a 0.18 hemoglobin gradient between affected and unaffected skin, the sensitivity of multispectral imaging for detecting progression in pediatric morphea is 90% with specificity of 100%. CONCLUSIONS: Multispectral imaging is a novel assessment tool with promising accuracy in predicting progression as an adjunct to clinical assessment in pediatric morphea. Further research should examine its performance against thermography.


Assuntos
Esclerodermia Localizada , Humanos , Criança , Feminino , Adolescente , Masculino , Esclerodermia Localizada/diagnóstico por imagem , Esclerodermia Localizada/tratamento farmacológico , Pele/diagnóstico por imagem , Progressão da Doença , Hemoglobinas/uso terapêutico
3.
An. bras. dermatol ; 91(4): 534-536, July-Aug. 2016. graf
Artigo em Inglês | LILACS | ID: lil-792449

RESUMO

Abstract: Lichen sclerosus is an uncommon inflammatory dermatosis with preferential involvement of the urogenital region. The extragenital involvement is uncommon and is characterized by small rounded macules or papules, pearly white in color. The coexistence of lichen sclerosus and scleroderma plaques in most cases with extragenital location has been reported in the literature. We report a case of lichen sclerosus associated with scleroderma in children, highlighting the importance of dermoscopy in diagnosis.


Assuntos
Humanos , Feminino , Criança , Esclerodermia Localizada/patologia , Esclerodermia Localizada/diagnóstico por imagem , Líquen Escleroso e Atrófico/patologia , Líquen Escleroso e Atrófico/diagnóstico por imagem , Dermoscopia/métodos , Esclerodermia Localizada/complicações , Pele/patologia , Pele/diagnóstico por imagem , Líquen Escleroso e Atrófico/complicações , Eritema/patologia , Eritema/diagnóstico por imagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA